Enliven Therapeutics shares owned by Fairmount Funds Management
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Fairmount Funds Management
from 13F filings
Historical chart of Fairmount Funds Management investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Fairmount Funds Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Fairmount Funds Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $76M | 3.7M | 20.47 |
| 2025-06-30 | $75M | 3.7M | 20.06 |
| 2025-03-31 | $63M | 3.2M | 19.68 |
| 2024-12-31 | $72M | 3.2M | 22.50 |
| 2024-09-30 | $82M | 3.2M | 25.54 |
| 2024-06-30 | $75M | 3.2M | 23.37 |
| 2024-03-31 | $56M | 3.2M | 17.59 |
| 2023-12-31 | $30M | 2.1M | 13.84 |
| 2023-09-30 | $29M | 2.1M | 13.66 |
| 2023-06-30 | $43M | 2.1M | 20.41 |
| 2023-03-31 | $42M | 1.9M | 21.90 |
More positions owned by Fairmount Funds Management
View all positions for Fairmount Funds Management